METFinancial Services · Insurance - LifeThe 18 Wall Street analysts covering MetLife, Inc. hold a median 12-month price target of $107 — +10.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 48 of 100 as at 19 Sept 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores MetLife, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (86): The shares have been drifting up relative to others.
Accruals (23): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on MET, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +10.3% from it.
Of the 20 most recent actions, 11 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 24 Aug 2026 | Morgan Stanley | Maintains | Overweight | $103 → $111 |
| 19 Aug 2026 | Wells Fargo | Maintains | Overweight | $101 → $109 |
| 11 Aug 2026 | JP Morgan | Maintains | Overweight | $106 → $108 |
| 11 Aug 2026 | JP Morgan | Maintains | Overweight | — |
| 11 Aug 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $105 → $108 |
| 11 Aug 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 6 Aug 2026 | Barclays | Maintains | Overweight | — |
| 6 Aug 2026 | Barclays | Maintains | Overweight | $94 → $97 |
| 22 July 2026 | TD Cowen | Maintains | Buy | $87 → $105 |
| 22 July 2026 | TD Cowen | Maintains | Buy | — |
| 21 July 2026 | JP Morgan | Maintains | Overweight | — |
| 21 July 2026 | JP Morgan | Maintains | Overweight | $96 → $106 |
| 13 July 2026 | Evercore ISI Group | Maintains | In-Line | $96 → $103 |
| 13 July 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 13 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $98 → $105 |
| 13 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 10 July 2026 | Jefferies | Maintains | Buy | — |
| 10 July 2026 | Jefferies | Maintains | Buy | $97 → $103 |
| 9 July 2026 | Mizuho | Maintains | Outperform | $95 → $102 |
| 9 July 2026 | Mizuho | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MET appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, MetLife, Inc. returned +26.2% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 39% of US stocks
Cheaper than 74% of US stocks
Cheaper than 41% of US stocks
Cheaper than 25% of US stocks
Higher than 53% of US stocks
Higher than 37% of US stocks
Higher than 56% of US stocks
Higher than 59% of US stocks
Higher than 71% of US stocks
Higher than 45% of US stocks
Higher than 52% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
MetLife, Inc. has a market value of $61.7B and an enterprise value of $85.2B.
Revenue in the twelve months to 30 June 2026: $77.7B. The latest quarter grew 10.5% year on year.
Net income over the same four quarters: $3.7B, a 4.7% net margin.
Diluted earnings per share, trailing twelve months: $5.23.
Free cash flow in the twelve months to 30 June 2026: $15.6B.
MetLife, Inc. spent $3.4B on share buybacks and $1.7B on dividends in the twelve months to 30 June 2026.
Trailing P/E: 18.6×; forward P/E: 8.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.44%, paying out 44% of earnings.
MetLife, Inc. employs 46,000 people — $1.7M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own MetLife, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks reported that annuity sales reached first-half record highs, and it highlighted MetLife alongside Prudential and Principal Financial as life insurers to watch as retirement needs and pension solutions grow.
Why it matters — Record annuity demand points to a favorable environment for MetLife's retirement and annuity businesses.
MetLife Investment Management, the institutional asset management business of MetLife, Inc., announced the closing of Galaxy 38 CLO, Ltd., a $450 million new issue collateralized loan obligation. PineBridge Investments, part of MIM, serves as collateral manager, with BofA Securities acting as arranger; it is the 45th CLO issuance by the Leveraged Finance team.
Why it matters — The closing of Galaxy 38 demonstrates continued activity and growth in MetLife Investment Management's leveraged finance and CLO issuance business.
The article highlights that elevated interest rates are benefiting insurance companies, including those offering dividend stocks, because the gap between collecting premiums now and paying claims years later becomes more profitable as rates stay high.
Why it matters — A MetLife watcher would care because higher rates can strengthen the profitability of insurance operations, which may matter for MetLife as a dividend-paying insurer.
MetLife, Inc. presented at the KBW Insurance Conference 2026, with a transcript of the event now available. The presentation covers the company's remarks at the insurance industry conference.
Why it matters — A MET watcher would care because the conference transcript provides direct insight into the company's commentary and positioning within the insurance sector.
An executive sold more than 6,000 shares of MetLife, Inc. at $95.17 per share, with the transaction valued at approximately $576,445. The shares represented about 2% of the executive's direct equity holdings prior to the sale.
Why it matters — A MetLife watcher would care because insider selling activity can be of interest when assessing executive behavior regarding the company's stock.
The 18 Wall Street analysts covering MetLife, Inc. have a median 12-month price target of $107, with estimates ranging from $84 to $119. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 18 analysts covering MetLife, Inc., 12 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks MetLife, Inc. 48 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 19 Sept 2026, MetLife, Inc. ranks 48 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (86 of 100).
No one can know that. What the data says: the median 12-month target from 18 analysts implies +10.3% from the last close, and Ticker Nerd's factor model ranks MetLife, Inc. 48 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering MetLife, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MET are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $84 to $119 over the next 12 months.
MetLife, Inc. returned +26.2% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
MetLife, Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers.
The most recent item we track (Zacks Investment Research, 17 Sept 2026): "3 Life Insurers to Watch as Annuity Sales Hit First-Half Record Highs". Zacks reported that annuity sales reached first-half record highs, and it highlighted MetLife alongside Prudential and Principal Financial as life insurers to watch as retirement needs and pension solutions grow.
MetLife, Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers. Its business spans group life, dental, disability, vision, accident and health coverage, along with retirement and income solutions such as pension risk transfer and structured settlements. MetLife also offers individual protection and savings products in international markets and serves corporate clients through a broad employee benefits platform. The company operates across major regions including the United States, Asia, Latin America, and Europe, the Middle East, and Africa, supported by diversified distribution channels that include employers, brokers, agents, and bancassurance partners. Through its insurance and investment businesses, MetLife plays a central role in helping households, employers, and institutions manage risk, protect assets, and fund long-term financial needs.
CEO Mr. Michel Abbas Khalaf · 46,000 employees · United States · https://www.metlife.com
